Diabetes imposes a heavy economic burden on India, with annual costs exceeding $10 billion—equivalent to 1.5% of the country’s GDP. This includes direct medical expenses (drugs, devices, hospitalizations) and indirect costs (lost productivity, reduced workforce participation). Yet, despite this strain, the India diabetes market is thriving, projected to reach $21.7 billion by 2030....
Portuguese 
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt